SUMMARY The limulus assay for the detection of bacterial endotoxin has been applied to the study of synovial fluid. Three of 5 patients (60%) with culture-positive gonococcal arthritis had positive SF limulus assay results; as did 2 of 11 (18%) with presumptive evidence of gonococcal arthritis, 3 of 6 (50%) with nongonococcal infectious arthritis, and none of 47 patients with noninfectious arthritis. Endotoxin levels ranged from 0 25 to 128*0 ng/ml. As at present applied to synovial fluid the commercial limulus assay appears to be specific for the infectious process but apparently lacks sensitivity.
The detection of endotoxin by a sensitive, rapid test has long been a goal of the microbiologist attempting to supplant the time-consuming procedures involved in bacterial cultures. Such a test might also be used to detect fastidious organisms which fail to grow if not properly transported or cultured. Thus a simple assay method that could be applied to clinical specimens would have considerable advantages. The limulus assay provides a means of detecting relatively low endotoxin concentrations (nglml) in clinical specimens1 and has been widely used.23 In some body fluids, such as the cerebrospinal fluid,4 it appears to be of value. In other body fluids, particularly blood plasma,5 6 its value is more problematical, at least partly because of the presence of substances7 which appear to inhibit the gelation reaction necessary for interpretation of the test.
It would seem to be particularly useful to apply a technique for endotoxin analysis to synovial fluid (SF), since Neisseria gonorrheae is a major cause of septic arthritis, produces endotoxin, and may escape detection unless transported and cultured under optimal conditions. Furthermore, should this assay, when applied to SF, prove sensitive and specific, it might help resolve the question of whether culturenegative arthritis occurring during disseminated gonococcal disease is due to the presence of undetected organisms in the joint or to some entirely different immunopathological process (e.g., immune
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For the purpose of this study infectious arthritis (8 patients) was defined as arthritis in which the SF culture was positive for bacteria. Presumed infectious arthritis (14 patients) was diagnosed when the clinician(s) caring for the patient viewed the arthritis as an infectious process but where the SF bacterial culture results were negative (6 patients) or the results unavailable (5 patients). Noninfectious arthritis (47 patients) was that in which the rheumatic condition appeared to be entirely unrelated to bacterial infection, with a negative SF culture.
Results
Synovial fluid was obtained from 69 patients. Table 1 shows the underlying joint diseases of these patients. Twenty-two patients had infectious or presumed infectious arthritis and 47 noninfectious conditions. The limulus assay was negative when performed on SF from all patients with noninfectious arthritis. Of the 8 patients with definite infectious arthritis 5 had positive limulus assays (Table 2 ). Included in these 8 patients were 5 with gonococcal arthritis, one with Thus, as with serum samples, we have found both false negative and false positive reactions. Conversely, however, it was important to note that false positive assays were not encountered in the group with noninfectious arthritis. The low sensitivity of the tests may relate to the dilution of the SF prior to assay.
Our results reported here differ from those of Elin et al.,8 who used their own lysate preparation. They found endotoxin could be detected in all cases of septic arthritis, including those with negative joint fluid cultures. They also found endotoxin could be found by the limulus assay in the SF of a substantial percentage of patients with rheumatoid arthritis, gout, Reiter's syndrome, and miscellaneous other conditions. They concluded that the limulus assay was not specific for septic processes. Tuazon et al.9 used the limulus assay to detect endotoxin in SF. They found 6 patients with culture-proved septic arthritis who had positive endotoxin assays, though 2 were patients with Gram-positive infections. The differences seen between the results of ourselves and Elin et al. may result from dissimilarities in the preparation of the lysate. We used a commercially available preparation. Using this lysate we found no false positives in patients with nonseptic conditions but failed to detect endotoxin in several culture-positive SF samples. It has previously been shown that the lysate used does effect the results of the assay.6 "'
As there appear to be some limitations with the limulus assay when applied to samples of SF, we are unable to draw any definite conclusions regarding patients with presumed gonococcal disease with negative limulus assays. However, when the assay was applied to SF with culture-negative gonococcal arthritis, which was definitely diagnosed in 6 patients in this study from the presence of positive gonococcal cultures at other sites, a negative limulus assay was present in 5 (83%). This would be compatible with our previous suggestions"2 that culture-negative gonococcal arthritis may result from either local formation of immune complexes within the SF or deposition within the synovial membrane of circulating immune complexes. Paralleling the data on serum analysis certain substance(s) appear to inhibit the gelation reaction, with resulting false negative results. This may afford an alternative explanation for some false negative results with SF, but it remains to be established.
Future research is being focused on the refinement of the limulus assay with respect to sensitivity and the elimination of potential false positive and false negative results, which are necessary before routine clinical application of this assay for synovial fluid analysis can be undertaken.
